Sun Pharmaceutical Industries Inc. has voluntarily recalled 5,344 bottles of bupropion hydrochloride extended-release (SR) tablets (150 mg), a prescription medication used to treat depression. The recall was issued because the tablets failed dissolution testing during stability checks, which means the medication might not release into the body as intended. No incidents or injuries have been reported, and the products were distributed to pharmacies across the United States.
Failed dissolution means the drug may not be absorbed properly by the body, which could result in the treatment being less effective than prescribed. While no injuries have been reported, inconsistent drug release can interfere with the management of medical conditions.
You have 2 options:
Quantity affected: 5,344 bottles. Manufactured by Sun Pharmaceutical Industries Limited, Gujrat, India; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.